What Researchers Did
Researchers described a personal method of hyperbaric treatment and reported its results in 50 patients with post-bronchitic emphysema, evaluating various organ functions.
What They Found
In 50 patients, hyperbaric treatment was found to quickly and effectively resolve alterations in haematosis and organic sequelae from respiratory insufficiency. When combined with other therapies, it was also capable of stopping or delaying the development of post-bronchitic emphysema.
What This Means for Canadian Patients
Canadian patients with post-bronchitic emphysema might benefit from hyperbaric oxygen therapy to improve respiratory function and manage related organ complications. This treatment, potentially alongside other medications, could offer a way to slow disease progression and enhance overall health.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's limitations include a small sample size of 50 patients and the absence of a control group for comparison.